Highlights
- By learning how rabies virus travels in the brain, Anti-Parkinson’s drug can be delivered deep in the brain where currently the drugs are not able to reach.
- Rabies virus has the capability to trick the nervous system and cross the blood brain barrier. This trick could be used for drug design.
- Glycoprotein 29 present on the rabies virus is attached to a nanoparticle stuffed full of deferoxamine ( Anti-Parkinson’s medication) and injected into the brain to trick the brain.
Researchers are now using a metal-grabbing compound called deferoxamine to sop up the excess iron in patients. But a large quantity of this drug needs to reach the brain in order for them work.
To usher deferoxamine into the brain, the researchers Yan-Zhong Chang, Xin Lou, Guangjun Nie took advantage of a key part of the rabies virus- Glycoprotein 29.
Glycoprotein 29 present on the rabies virus is attached to a nanoparticle stuffed full of deferoxamine ( Anti-Parkinson’s medication) and injected into the brain to trick the brain.
When they injected this iron-grabbing nanoparticles into mouse models of Parkinson’s disease, the iron levels in the mouse models dropped and this reduced brain damage caused by Parkinson’s disease.
- Linhao You, Jing Wang, Tianqing Liu, Yinlong Zhang, Xuexiang Han, Ting Wang, Shanshan Guo, Tianyu Dong, Junchao Xu, Gregory J. Anderson, Qiang Liu, Yan-Zhong Chang, Xin Lou, and Guangjun Nie . Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice, ACS Nano (2018).DOI: 10.1021/acsnano.7b08172
Source-Medindia